Pharmidex attending BioTrinity 2018

April 20, 2018

BioTrinity 2018 will take place over two and a half days from Monday 23rd to Wednesday 25th April.

Pharmidex will be attending this year BioTrinity 2018 conference between the 23-25th of April.

"Our goal for BioTrinity 2018 was simple – to create an ideal network and partnering platform for the global life sciences industry under one roof, ultimately to help shape our healthcare future."

"Our theme for BioTrinity 2018 was 'Next Generation Healthcare' which was explored via a range of insightful keynote and panel discussions including 'AI and Drug Discovery', 'An insight into Nanotechnology', 'Next Generation Chemistry' and 'The Evolution of the Life Science Investment Industry'

We look forward to meeting you at BioTrinity, please pop by and say hello!

< Older Post

Newer Post >

🌟 Pharmidex is proud to sponsor CamMedChem’25! 🌟

September 12, 2025

We’re delighted to announce that Pharmidex will be an official sponsor of CamMedChem’25 , the renowned meeting organized by the Royal Society of Chemistry’s Biomolecular Chemistry Special Interest Group This year’s theme promises cutting-edge discussions in medicinal chemistry, biomolecular interactions and the latest trends in small molecule and chemical biology research. We’re honoured to support such a pivotal forum for scientists, drug discovery experts and academic innovators to exchange ideas, foster collaborations, and advance therapeutic discovery. 👉 We look forward to: Learning from the powerful scientific insights shared at the meeting Exploring new partnerships that further the translation of biomolecular science into impactful therapies We can’t wait to see you in Cambridge for CamMedChem’25!

Pharmidex Histology Services: Precision You Can Trust

September 8, 2025

At Pharmidex , we deliver comprehensive histology solutions designed to support preclinical and clinical research with accuracy and reliability. 🔬 From sample to slide, our services include: tissue processing, embedding, microtomy, routine and special staining, digital imaging and slide scanning all underpinned by rigorous quality control and expert scientific oversight. With specialist capabilities and high-throughput workflows, we help researchers generate high-quality, reproducible data across toxicology, oncology, CNS and beyond. 👉 Learn more: pharmidex.com/histology

🔬 Expanding our integrated capabilities in autoimmune research

September 3, 2025

At Pharmidex , we are proud to offer a comprehensive preclinical platform for autoimmune disease research. Using in vivo EAE models, we combine: ✔️ Bioanalysis & biomarker profiling to quantify key cytokines and mediators of disease progression ✔️ Histological assessment, enabling detailed evaluation of inflammation, demyelination and tissue pathology across multiple organs ✔️ Pharmacological intervention studies, including established treatments such as Fingolimod for validation This integrated approach delivers a complete and translationally relevant dataset, supporting drug discovery and development programmes from mechanistic insight through to therapeutic evaluation. By combining in vivo efficacy, biomarker analysis and histology, our team provides partners with a more comprehensive understanding of disease mechanisms and treatment effects. 👉 Learn more about our services in Histology, Biomarker Analysis, and Autoimmune Disease Models.